These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 24923464

  • 1. Neuroprotective effects of metallothionein against rotenone-induced myenteric neurodegeneration in parkinsonian mice.
    Murakami S, Miyazaki I, Sogawa N, Miyoshi K, Asanuma M.
    Neurotox Res; 2014 Oct; 26(3):285-98. PubMed ID: 24923464
    [Abstract] [Full Text] [Related]

  • 2. Effects of Enteric Environmental Modification by Coffee Components on Neurodegeneration in Rotenone-Treated Mice.
    Miyazaki I, Isooka N, Wada K, Kikuoka R, Kitamura Y, Asanuma M.
    Cells; 2019 Mar 07; 8(3):. PubMed ID: 30866481
    [Abstract] [Full Text] [Related]

  • 3. Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: Possibly involvement of metallothionein expression in astrocytes.
    Isooka N, Miyazaki I, Kikuoka R, Wada K, Nakayama E, Shin K, Yamamoto D, Kitamura Y, Asanuma M.
    Neurochem Int; 2020 Jan 07; 132():104608. PubMed ID: 31765686
    [Abstract] [Full Text] [Related]

  • 4. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
    Sharma SK, Ebadi M.
    Antioxid Redox Signal; 2003 Jun 07; 5(3):251-64. PubMed ID: 12880480
    [Abstract] [Full Text] [Related]

  • 5. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease.
    Miyazaki I, Isooka N, Imafuku F, Sun J, Kikuoka R, Furukawa C, Asanuma M.
    Int J Mol Sci; 2020 May 04; 21(9):. PubMed ID: 32375371
    [Abstract] [Full Text] [Related]

  • 6. Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson's Disease in Mice.
    Murakami S, Miyazaki I, Miyoshi K, Asanuma M.
    Neurochem Res; 2015 Jun 04; 40(6):1165-78. PubMed ID: 25894684
    [Abstract] [Full Text] [Related]

  • 7. Central and Enteric Neuroprotective Effects by Eucommia ulmoides Extracts on Neurodegeneration in Rotenone-induced Parkinsonian Mouse.
    Imafuku F, Miyazaki I, Sun J, Kamimai S, Shimizu T, Toyota T, Okamoto Y, Isooka N, Kikuoka R, Kitamura Y, Asanuma M.
    Acta Med Okayama; 2022 Aug 04; 76(4):373-383. PubMed ID: 36123151
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats.
    Teerapattarakan N, Benya-Aphikul H, Tansawat R, Wanakhachornkrai O, Tantisira MH, Rodsiri R.
    Phytomedicine; 2018 May 15; 44():65-73. PubMed ID: 29895494
    [Abstract] [Full Text] [Related]

  • 9. Kolaviron protects against nigrostriatal degeneration and gut oxidative damage in a stereotaxic rotenone model of Parkinson's disease.
    Farombi EO, Awogbindin IO, Olorunkalu PD, Ogbuewu E, Oyetunde BF, Agedah AE, Adeniyi PA.
    Psychopharmacology (Berl); 2020 Nov 15; 237(11):3225-3236. PubMed ID: 32651640
    [Abstract] [Full Text] [Related]

  • 10. Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.
    Ojha S, Javed H, Azimullah S, Abul Khair SB, Haque ME.
    Neurotox Res; 2016 Feb 15; 29(2):275-87. PubMed ID: 26607911
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection.
    Kikuoka R, Miyazaki I, Kubota N, Maeda M, Kagawa D, Moriyama M, Sato A, Murakami S, Kitamura Y, Sendo T, Asanuma M.
    Sci Rep; 2020 Nov 26; 10(1):20698. PubMed ID: 33244123
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats.
    Horst CH, Schlemmer F, de Aguiar Montenegro N, Domingues ACM, Ferreira GG, da Silva Ribeiro CY, de Andrade RR, Del Bel Guimarães E, Titze-de-Almeida SS, Titze-de-Almeida R.
    Neurochem Res; 2018 Nov 26; 43(11):2132-2140. PubMed ID: 30267378
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease.
    Jarras H, Bourque M, Poirier AA, Morissette M, Coulombe K, Di Paolo T, Soulet D.
    J Neuroendocrinol; 2020 Jan 26; 32(1):e12782. PubMed ID: 31430407
    [Abstract] [Full Text] [Related]

  • 18. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
    Takeuchi H, Yanagida T, Inden M, Takata K, Kitamura Y, Yamakawa K, Sawada H, Izumi Y, Yamamoto N, Kihara T, Uemura K, Inoue H, Taniguchi T, Akaike A, Takahashi R, Shimohama S.
    J Neurosci Res; 2009 Feb 26; 87(2):576-85. PubMed ID: 18803299
    [Abstract] [Full Text] [Related]

  • 19. Mechanistic comparison between MPTP and rotenone neurotoxicity in mice.
    Bhurtel S, Katila N, Srivastav S, Neupane S, Choi DY.
    Neurotoxicology; 2019 Mar 26; 71():113-121. PubMed ID: 30605763
    [Abstract] [Full Text] [Related]

  • 20. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone.
    Inden M, Kitamura Y, Takeuchi H, Yanagida T, Takata K, Kobayashi Y, Taniguchi T, Yoshimoto K, Kaneko M, Okuma Y, Taira T, Ariga H, Shimohama S.
    J Neurochem; 2007 Jun 26; 101(6):1491-1504. PubMed ID: 17459145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.